MoneyWorks4Me

Vivimed Labs board to consider final dividend

18 May 2012 Evaluate

Vivimed Labs has informed that a meeting of the board of directors of the company will be held on May 30, 2012, to consider the audited financial results for financial year ended March 31, 2012 and to consider recommendation of final dividend for financial year ended March 31, 2012.

The above information is part of company’s filing submitted to the BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..